Sector News

Edwards Announces Board Change

October 6, 2014
Life sciences
/PRNewswire/ – Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that David E.I. Pyott, a member of the company’s Board of Directors, has submitted his resignation, effective today, in order to devote more time to his role as chairman and chief executive officer of Allergan, Inc.
 
“The board and I are truly appreciative of David’s service and commitment to Edwards during the last 14 years,” said Michael A. Mussallem, Edwards’ chairman and CEO.  “David’s extensive global experience in leadership roles at innovative health and nutrition companies made him a valuable resource for our company.  He has been a trusted partner and brought important expertise to Edwards in delivering novel therapies to address the needs of patients.  We wish him the best and thank him for the significant role he has played in Edwards’ growth and success.”
 
Pyott joined Edwards’ board of directors in 2000, when Edwards was established as an independent, publicly-held corporation.
 
Source: Edwards Lifesciences Corporation

comments closed

Related News

October 17, 2021

Colorcon acquires a majority share in Ideal Cures Pvt. Ltd., India

Life sciences

Ideal Cures will operate as a fully independent entity within Colorcon. Their business complements Colorcon’s position in the Indian pharmaceutical market with a strong presence in the domestic generic sector comprised of long-standing customer relationships sustained by innovative and customized solutions.

October 17, 2021

Barriers exist, but participation urgent in breast cancer clinical trials: report

Life sciences

Across four new breast cancer treatments approved by the FDA last year, 2% to 9% of patients in clinical trials for the drugs were Black Americans and 0% to 9% were Hispanic, according to a new report from Breastcancer.org.

October 17, 2021

Danish consortium acquires part of Jernbanebyen to create one of the world’s healthiest urban villages

Life sciences

The southern section of Jernbanebyen in central Copenhagen has a new owner. The Baneby Consortium, comprising NREP, Novo Holdings and Industriens Pension, has bought the land from Freja Ejendomme. The ambition is to create a green, partly car-free environment that will also be one of the healthiest in the world. 

Send this to a friend